Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Update on offer for subscription

28 Aug 2019 07:00

RNS Number : 3234K
Amati AIM VCT PLC
28 August 2019
 

Amati AIM VCT plc

28 August 2019

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Update on offer for subscription

Following the announcement made on 26 June 2019, the Board has been discussing the size and structure of the proposed offer for subscription (the "Offer") with the Investment Manager. Having considered the deployment of funds over the last six months and the current pipeline of investment opportunities, the Company is seeking to raise £25 million over a 12 month period from the date of the prospectus. The Directors will also have discretion to utilise an over-allotment facility of up to £20 million, either in whole or in part. This facility will only be utilised if the Directors are satisfied that there is a suitable pipeline of investments to deploy the extra funds and if there is sufficient demand from investors.

In addition, provision is being made for up to a further £5 million to be raised from the Company's Dividend Re-Investment Scheme over the course of the Offer.

In order to ensure the efficient deployment of funds and to provide the Company with greater flexibility, the amount to be raised under the Offer prior to the Company's year end on 31 January 2020 will be capped at £15 million.

Further details of the Offer will be provided in a prospectus to be published by the Company around the end of October 2019. A further announcement will be released when the prospectus is available.

For further information, please contact Samantha Dalby on +44 (0)131 503 9115 or email: info@amatiglobal.com

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDPRMFTMBITBBL
Date   Source Headline
24th Jun 20242:08 pmRNSNet Asset Value(s)
21st Jun 20244:17 pmRNSTransaction in Own Shares
14th Jun 20244:47 pmRNSNet Asset Value(s)
13th Jun 20244:20 pmRNSResult of AGM
10th Jun 202410:01 amRNSNet Asset Value(s)
6th Jun 20243:08 pmRNSTransaction in Own Shares
3rd Jun 20244:21 pmRNSNet Asset Value(s)
3rd Jun 20243:20 pmRNSTotal Voting Rights
28th May 20241:59 pmRNSNet Asset Value(s)
23rd May 20245:10 pmRNSTransaction in Own Shares
20th May 20245:06 pmRNSTransaction in Own Shares
20th May 20243:46 pmRNSTransaction in Own Shares
17th May 20244:27 pmRNSNet Asset Value(s)
16th May 202412:15 pmRNSTransaction in Own Shares
16th May 20247:00 amRNSTransaction in Own Shares
13th May 202410:28 amRNSNet Asset Value(s)
9th May 20243:41 pmRNSStrategic Review and Special Dividend
2nd May 202410:38 amRNSNet Asset Value(s)
1st May 20243:59 pmRNSTotal Voting Rights
30th Apr 20245:03 pmRNSTransaction in Own Shares
26th Apr 20244:29 pmRNSNet Asset Value(s)
22nd Apr 202411:21 amRNSNet Asset Value(s)
15th Apr 202410:36 amRNSNet Asset Value(s)
12th Apr 20247:00 amRNSAnnual Financial Report
8th Apr 202411:58 amRNSNet Asset Value(s)
3rd Apr 20241:04 pmRNSNet Asset Value(s)
3rd Apr 202412:15 pmRNSTransaction in Own Shares
2nd Apr 202411:06 amRNSTotal Voting Rights
25th Mar 20242:26 pmRNSTransaction in Own Shares
25th Mar 202412:39 pmRNSNet Asset Value(s)
18th Mar 20241:55 pmRNSNet Asset Value(s)
15th Mar 20243:00 pmRNSTransaction in Own Shares
14th Mar 20245:11 pmRNSCompliance with Market Abuse Regulation
14th Mar 20247:00 amRNSStrategic Review
11th Mar 202410:12 amRNSNet Asset Value(s)
4th Mar 20249:55 amRNSNet Asset Value(s)
1st Mar 20244:18 pmRNSTotal Voting Rights
29th Feb 20242:27 pmRNSTransaction in Own Shares
26th Feb 202410:03 amRNSNet Asset Value(s)
19th Feb 202410:21 amRNSNet Asset Value(s)
14th Feb 20244:36 pmRNSTransaction in Own Shares
9th Feb 20244:56 pmRNSNet Asset Value(s)
2nd Feb 20246:03 pmRNSTransaction in Own Shares
2nd Feb 202412:15 pmRNSNet Asset Value(s)
1st Feb 20242:21 pmRNSTotal Voting Rights
29th Jan 202411:53 amRNSNet Asset Value(s)
26th Jan 20245:14 pmRNSTransaction in Own Shares
19th Jan 20245:03 pmRNSNet Asset Value(s)
16th Jan 20244:34 pmRNSTransaction in Own Shares
15th Jan 20244:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.